Success Stories in mRNA Vaccine Development
mRNA manufacturing
Establishing capacity for manufacturing mRNA therapeutics and vaccines can be complicated, especially when the urgent needs require production readiness.
This whitepaper discusses how public-private collaboration enabled technology development and established the infrastructure for mRNA R&D and production capacity in Africa.
To download this whitepaper, please complete the webform.